4.7 Review

Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease

Journal

TOXINS
Volume 11, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/toxins11100578

Keywords

AGEs; diabetic kidney disease; endothelial dysfunction; glucose; polyols

Ask authors/readers for more resources

Alterations of renal endothelial cells play a crucial role in the initiation and progression of diabetic kidney disease. High glucose per se, as well as glucose by-products, induce endothelial dysfunction in both large vessels and the microvasculature. Toxic glucose by-products include advanced glycation end products (AGEs), a group of modified proteins and/or lipids that become glycated after exposure to sugars, and glucose metabolites produced via the polyol pathway. These glucose-related endothelio-toxins notably induce an alteration of the glomerular filtration barrier by increasing the permeability of glomerular endothelial cells, altering endothelial glycocalyx, and finally, inducing endothelial cell apoptosis. The glomerular endothelial dysfunction results in albuminuria. In addition, high glucose and by-products impair the endothelial repair capacities by reducing the number and function of endothelial progenitor cells. In this review, we summarize the mechanisms of renal endothelial toxicity of high glucose/glucose by-products, which encompass changes in synthesis of growth factors like TGF-beta and VEGF, induction of oxidative stress and inflammation, and reduction of NO bioavailability. We finally present potential therapies to reduce endothelial dysfunction in diabetic kidney disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry

Michele Iudici, Christian Pagnoux, Delphine S. Courvoisier, Pascal Cohen, Antoine Neel, Achille Aouba, Francois Lifermann, Marc Ruivard, Olivier Aumaitre, Bernard Bonnotte, Francois Maurier, Thomas Le Gallou, Eric Hachulla, Alexandre Karras, Chahera Khouatra, Noemie Jourde-Chiche, Jean-Francois Viallard, Claire Blanchard-Delaunay, Pascal Godmer, Alain Le Quellec, Thomas Quemeneur, Claire de Moreuil, Alexis Regent, Benjamin Terrier, Luc Mouthon, Loic Guillevin, Xavier Puechal

Summary: Patients with localized granulomatosis with polyangiitis (L-GPA) present with different clinical features compared to systemic GPA (S-GPA), with younger age, less frequent saddle nose deformity or subglottic stenosis, and lower PR3-ANCA positivity. Treatment strategies also vary, with less frequent use of CYC and more frequent use of a combination of MTX and glucocorticoids in L-GPA patients. Despite similar relapse risks between L-GPA and S-GPA, L-GPA patients have higher overall survival rates and more frequent relapses in the ENT and lung regions.

RHEUMATOLOGY (2022)

Review Rheumatology

Bartonella and Coxiella infections presenting as systemic vasculitis: case series and review of literature

Maxime Beydon, Christophe Rodriguez, Alexandre Karras, Alexandre Cez, Cedric Rafat, Noemie Jourde-Chiche, Olivier Fain, Carole Philipponnet, Xavier Puechal, Antoine Dossier, Nicolas Dupin, Dan Levy, Ines Aureau, Loic Guillevin, Benjamin Terrier

Summary: Through a case series and literature review, it was found that Bartonella infection can mimic PR3-ANCA-associated vasculitis with involvement of the kidneys and endocarditis, while Coxiella infection may induce vasculitis affecting vessels of all sizes, with 75% presenting as cryoglobulinaemia vasculitis.

RHEUMATOLOGY (2022)

Article Urology & Nephrology

Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges

Dorian Nezam, Raphael Porcher, Francois Grolleau, Pauline Morel, Dimitri Titeca-Beauport, Stanislas Faguer, Alexandre Karras, Justine Solignac, Noemie Jourde-Chiche, Francois Maurier, Hamza Sakhi, Khalil El Karoui, Rafik Mesbah, Pierre Louis Carron, Vincent Audard, Didier Ducloux, Romain Paule, Jean-Fracois Augusto, Julien Aniort, Aurelien Tiple, Cedric Rafat, Severine Beaudreuil, Xavier Puechal, Pierre Gobert, Ziad Massy, Catherine Hanrotel, Stephane Bally, Nihal Martis, Cecile-Audrey Durel, Geoffroy Desbuissons, Pascal Godmer, Aurelie Hummel, Francois Perrin, Antoine Neel, Claire De Moreuil, Tiphaine Goulenok, Dominique Guerrot, Steven Grange, Aurelie Foucher, Alban Deroux, Carole Cordonnier, Celine Guilbeau-Frugier, Anne Modesto-Segonds, Dominique Nochy, Laurent Daniel, Anissa Moktefi, Marion Rabant, Loic Guillevin, Alexis Regent, Benjamin Terrier

Summary: The study found that PLEX did not improve the primary outcome in the entire population, but identified a subset of patients who could benefit from PLEX. However, these findings need to be validated before being used in clinical decision making.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Transplantation

Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis

Guillaume Lano, Marion Sallee, Marion Pelletier, Stanislas Bataille, Megan Fraisse, Nathalie McKay, Philippe Brunet, Laetitia Dou, Stephane Burtey

Summary: This study found that the neutrophil:lymphocyte ratio (NLR) can predict mortality and cardiovascular events in hemodialysis (HD) patients, and it is positively correlated with the level of the uremic toxin indoxyl sulfate (IS).

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Transplantation

Mechanisms of myostatin and activin A accumulation in chronic kidney disease

Stanislas Bataille, Laetitia Dou, Marc Bartoli, Marion Sallee, Julien Aniort, Borhane Ferkak, Rania Chermiti, Nathalie McKay, Nathalie Da Silva, Stephane Burtey, Stephane Poitevin

Summary: In chronic kidney disease (CKD), the plasma concentrations of myostatin and activin A are increased, possibly due to reduced renal clearance. Furthermore, we observed increased production of activin A in the kidney and heart, which may be related to muscle wasting. Therefore, myostatin and activin A should be added to the list of uremic toxins.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Rheumatology

Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial

Noemie Jourde-Chiche, Nathalie Costedoat-Chalumeau, Karine Baumstarck, Anderson Loundou, Laurence Bouillet, Stephane Burtey, Valerie Caudwell, Laurent Chiche, Lionel Couzi, Laurent Daniel, Christophe Deligny, Bertrand Dussol, Stanislas Faguer, Pierre Gobert, Guillaume Gondran, Antoine Huart, Aurelie Hummel, Emilie Kalbacher, Adexandre Karras, Marc Lambert, Veronique Le Guern, Ludivine Lebourg, Sandrine Loubiere, Helene Maillard-Lefebvre, Francois Maurier, Micheline Pha, Viviane Queyrel, Philippe Remy, Francoise Sarrot-Reynauld, David Verhelst, Eric Hachulla, Zahir Amoura, Eric Daugas

Summary: For patients with proliferative lupus nephritis, discontinuation of maintenance immunosuppressive therapy (IST) after 2.3 years is not non-inferior to continuation of IST. However, IST discontinuation is associated with a higher risk of severe systemic lupus erythematosus (SLE) flares.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Dermatology

CD146 at the Interface between Oxidative Stress and the Wnt Signaling Pathway in Systemic Sclerosis

Xavier Heim, Julien Bermudez, Ahmad Joshkon, Elise Kaspi, Richard Bachelier, Marie Nollet, Melanie Velier, Laetitia Dou, Alexandre Brodovitch, Alexandrine Foucault-Bertaud, Aurelie S. Leroyer, Audrey Benyamine, Aurelie Daumas, Brigitte Granel, Florence Sabatier, Francoise Dignat-George, Marcel Blot-Chabaud, Nathalie Bardin

Summary: This study reveals the involvement of CD146 in the regulation of Wnt/ROS signaling in skin fibrosis of systemic sclerosis. The absence of CD146 leads to procanonical Wnt signaling, increased ROS content, and DNA oxidative damage. Furthermore, CD146 and its ligand are upregulated in fibroblasts from patients with systemic sclerosis. These findings highlight the importance of CD146 in the pathogenesis of systemic sclerosis and provide insights for innovative therapeutic strategies.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Urology & Nephrology

Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy

Sophie Chauvet, Jill J. Hauer, Florent Petitprez, Marion Rabant, Paula Vieira Martins, Veronique Baudouin, Yahsou Delmas, Noemie Jourde-Chiche, Alexandre Cez, David Ribes, Sylvie Cloarec, Aude Servais, Mohamad Zaidan, Eric Daugas, Michel Delahousse, Alain Wynckel, Amelie Ryckewaert, Anne Laure Sellier-Leclerc, Olivia Boyer, Eric Thervet, Alexandre Karras, Richard J. H. Smith, Veronique Fremeaux-Bacchi

Summary: C3 glomerulopathy (C3G) is a rare complement-mediated disease. The prognosis of this disease is associated with age, kidney function and genetic variants in complement genes. Blood biomarker analysis can predict the kidney outcome of patients.

KIDNEY INTERNATIONAL (2022)

Letter Urology & Nephrology

Reply to 'Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C?'

Justine Solignac, Noemie Jourde-Chiche

CLINICAL KIDNEY JOURNAL (2023)

Article Food Science & Technology

Protein/Fiber Index Modulates Uremic Toxin Concentrations in Hemodialysis Patients

Manon Ebersolt, Tacy Santana Machado, Cecilia Mallmann, Nathalie Mc-Kay, Laetitia Dou, Dammar Bouchouareb, Philippe Brunet, Stephane Burtey, Marion Sallee

Summary: A low protein/fiber index is associated with lower concentrations of uremic toxins in anuric hemodialysis patients. Diets with increased fiber intake should be tested to determine if they can reduce serum concentrations of p-cresyl sulfate and indoxyl sulfate.

TOXINS (2022)

Article Biochemistry & Molecular Biology

Systematic Comparison of Uremic Toxin Removal Using Different Hemodialysis Modes: A Single-Center Crossover Prospective Observational Study

Ariane Duval-Sabatier, Stephane Burtey, Marion Pelletier, Manon Laforet, Laetitia Dou, Marion Sallee, Anne-Marie Lorec, Hafssa Knidiri, Floriane Darbon, Yvon Berland, Philippe Brunet

Summary: Hemodialysis can reduce uremic toxins, and hemodiafiltration improves the removal of middle molecules. However, it has no effect on indoles concentration, and different treatment methods do not significantly differ in the removal of protein-bound solutes.

BIOMEDICINES (2023)

Article Rheumatology

Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures

Robin Arcani, Elisabeth Jouve, Laurent Chiche, Noemie Jourde-Chiche

Summary: We developed a type 2 score derived from the SF-36 to categorize SLE patients and compared immunological and transcriptomic profiles between groups.

CLINICAL RHEUMATOLOGY (2023)

Article Transplantation

Indoxyl sulfate inhibits muscle cell differentiation via Myf6/MRF4 and MYH2 downregulation

Stanislas Bataille, Nathalie McKay, Laetitia Koppe, Alice Beau, Berengere Benoit, Marc Bartoli, Nathalie Da Silva, Stephane Poitevin, Julien Aniort, Rania Chermiti, Stephane Burtey, Laetitia Dou

Summary: Indoxyl sulfate (IS), an indolic uremic toxin, inhibits the expression of Myf6/MRF4 and MYH2 during muscle cell differentiation, leading to a defect in myotube structure. This provides new insights into the role of IS in muscle atrophy observed in CKD.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Rheumatology

Lupus activity and outcomes in lupus patients undergoing maintenance dialysis

Francois Gaillard, Delphine Bachelet, Cecile Couchoud, Cedric Laouenan, Katell Peoc'h, Quentin Simon, Nicolas Charles, Noemie Jourde-Chiche, Eric Daugas

Summary: This study found that lupus activity decreases after the initiation of maintenance dialysis, but non-severe and severe lupus flares still occur. It emphasizes the importance of continued follow-up of lupus patients by specialists after dialysis initiation.

RHEUMATOLOGY (2023)

Article Urology & Nephrology

Kidney Biopsy in Type 2 Diabetes: A Multicenter Cross-Sectional Study

Jonathan M. Chemouny, Mickael Bobot, Aurelie Sannier, Valentin Maisons, Noemie Jourde-Chiche, Elsa Ferriere, Dominique Joly, Cecile Vigneau, Nathalie Rioux-Leclercq, Christophe Barba, Laurent Daniel, Jean-Michel Halimi, Francois Vrtovsnik

Summary: Kidney biopsies are commonly performed on patients with type 2 diabetes to differentiate between non-diabetic or hypertensive kidney disease and diabetic or hypertensive nephropathy. This study evaluated the association of different patterns of atypical features or KB indications with non-diabetic or hypertensive kidney disease. Results showed that despite the presence of hematuria, it is not sufficient to indicate kidney biopsy in the absence of other atypical features, while rapid progression of proteinuria and deterioration of eGFR are major indicators of non-diabetic or hypertensive kidney disease.

AMERICAN JOURNAL OF NEPHROLOGY (2021)

No Data Available